(Q44256494)

1 December 2017

title

Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis (English)

1 reference

1 December 2017

D C Metz

1

1 reference

1 December 2017

W J Bochenek

series ordinal

2

1 reference

1 December 2017

Pantoprazole US GERD Study Group

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Alimentary Pharmacology & Therapeutics

1 December 2017

published in

1 reference

1 December 2017

volume

17

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

155-164

1 reference

Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01410.X

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01410.X

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01410.X

Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01410.X

Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01410.X

10.1046/J.1365-2036.2003.01410.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference